Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression

MLA

Devadarssen Murdamoothoo, et al. “Tenascin‐C Immobilizes Infiltrating T Lymphocytes through CXCL12 Promoting Breast Cancer Progression.” EMBO Molecular Medicine, vol. 13, no. 6, May 2021, pp. 1–21. EBSCOhost, https://doi.org/10.15252/emmm.202013270.

APA

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, Gilles Riegel, Chérine Abou‐Faycal, Claire Deligne, Ines Velazquez‐Quesada, William Erne, Marine Nascimento, Matthias Mörgelin, Gérard Cremel, Nicodème Paul, Raphael Carapito, Romain Veber, Hélène Dumortier, Jingping Yuan, Kim S Midwood, Thomas Loustau, & Gertraud Orend. (2021). Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Molecular Medicine, 13(6), 1–21. https://doi.org/10.15252/emmm.202013270

Chicago

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, Gilles Riegel, Chérine Abou‐Faycal, Claire Deligne, Ines Velazquez‐Quesada, et al. 2021. “Tenascin‐C Immobilizes Infiltrating T Lymphocytes through CXCL12 Promoting Breast Cancer Progression.” EMBO Molecular Medicine 13 (6): 1–21. doi:10.15252/emmm.202013270.